Senores Pharmaceuticals Ltd. NSE: SENORES | BSE: 544319

Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Name: Senores Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Senores Pharmaceuticals Ltd.
Rating: 2.643708375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

803.15 -9.80 (-1.21%)

New 52W High in past week

121.7K

NSE+BSE Volume

NSE 14 Jan, 2026 3:46 PM (IST)

Board Meeting

The next board meeting for Senores Pharmaceuticals is on 20 Jan 2026 for the purpose of Quarterly Results See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

60.3 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

986

1Yr Price target upside is 23%

4 analysts

Senores Pharmaceuticals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

New 52W High in past week

SWOT Analysis

Senores Pharmaceuticals Live Price Chart